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7RESEARCH Open AccessHeart–lung interactions during neurally adjusted
ventilatory assist
David Berger1†, Stefan Bloechlinger1,2†, Jukka Takala1, Christer Sinderby3,4 and Lukas Brander1,5*Abstract
Introduction: Assist in unison to the patient’s inspiratory neural effort and feedback-controlled limitation of lung
distension with neurally adjusted ventilatory assist (NAVA) may reduce the negative effects of mechanical ventilation
on right ventricular function.
Methods: Heart–lung interaction was evaluated in 10 intubated patients with impaired cardiac function using
esophageal balloons, pulmonary artery catheters and echocardiography. Adequate NAVA level identified by a
titration procedure to breathing pattern (NAVAal), 50% NAVAal, and 200% NAVAal and adequate pressure support
(PSVal, defined clinically), 50% PSVal, and 150% PSVal were implemented at constant positive end-expiratory
pressure for 20 minutes each.
Results: NAVAal was 3.1 ± 1.1cmH2O/μV and PSVal was 17 ± 2 cmH20. For all NAVA levels negative esophageal
pressure deflections were observed during inspiration whereas this pattern was reversed during PSVal and PSVhigh.
As compared to expiration, inspiratory right ventricular outflow tract velocity time integral (surrogating stroke
volume) was 103 ± 4%, 109 ± 5%, and 100 ± 4% for NAVAlow, NAVAal, and NAVAhigh and 101 ± 3%, 89 ± 6%, and
83 ± 9% for PSVlow, PSVal, and PSVhigh, respectively (p < 0.001 level-mode interaction, ANOVA). Right ventricular
systolic isovolumetric pressure increased from 11.0 ± 4.6 mmHg at PSVlow to 14.0 ± 4.6 mmHg at PSVhigh but remained
unchanged (11.5 ± 4.7 mmHg (NAVAlow) and 10.8 ± 4.2 mmHg (NAVAhigh), level-mode interaction p = 0.005). Both
indicate progressive right ventricular outflow impedance with increasing pressure support ventilation (PSV), but no
change with increasing NAVA level.
Conclusions: Right ventricular performance is less impaired during NAVA compared to PSV as used in this
study. Proposed mechanisms are preservation of cyclic intrathoracic pressure changes characteristic of
spontaneous breathing and limitation of right-ventricular outflow impedance during inspiration, regardless of
the NAVA level.
Trial registration: Clinicaltrials.gov Identifier: NCT00647361, registered 19 March 2008Introduction
Cyclic increases in intrathoracic pressure during positive
pressure ventilation may reduce venous return and
increase the afterload of the right ventricle [1,2]. Neurally
adjusted ventilatory assist (NAVA) delivers inspiratory
support in synchrony and in linear proportion to the
neural inspiratory effort by using the electrical activity of* Correspondence: lukas.brander@luks.ch
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unless otherwise stated.the diaphragm (EAdi) to drive the ventilator [3]. The in-
spiratory muscle activity, that is synchronous and propor-
tional to assist delivery during NAVA, is likely to attenuate
the increases in pleural pressure associated with conven-
tional positive pressure ventilation. This attenuation should
reduce negative effects of positive pressure ventilation on
cardiovascular function. Data on cardiovascular function
during NAVA are very limited. The cardiovascular effects
of NAVA depend on the pleural pressure changes and
the consequent transmural vascular and cardiac pres-
sures, but these have not so far been studied.
We hypothesized that the synchronous inspiratory
muscle activity during NAVA and the feedback controlled
limitation of lung volumes during increasing NAVALtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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support ventilation (PSV) on right ventricular afterload and
venous return. We therefore compared the short-term
hemodynamic effects of three NAVA and three PSV levels
using simultaneous analysis of intravascular, intracardiac,
esophageal pressure (Pes), airway pressure, breathing pat-
tern, and echocardiography in patients with impaired cardiac
function, chronic obstructive pulmonary disease, or both.
Materials and methods
The Ethics Committee of Canton Bern, Switzerland
approved the protocol (KEK Nr 217–06). Recruitment
lasted from March to November 2010. Written informed
consent from the patient’s family and deferred consent
after recovery were obtained. A detailed description of the
methods is provided in Additional file 1.
The main inclusion criteria were invasive mechanical
ventilation, pneumatic triggering, pulmonary artery
catheter monitoring for clinical reasons, and at least
one of the following: left ventricular ejection fraction
≤40%; inotropic drugs (dobutamine ≥2 μg/kg/minute
or adrenaline ≥0.03 μg/kg/minute); pulmonary artery
occlusion pressure ≥18 mmHg; or history of chronic
obstructive pulmonary disease.
Study protocol
Catheters were inserted for measurement of Pes (SmartCath;
Viasys Healthcare, San Diego, CA, USA) and EAdi (Maquet,
Solna, Sweden). Correct positioning of the Pes catheter was
verified using an occlusion test [4,5]. A schematic study
protocol is depicted in Figure 1.
Adequate PSV (PSVal) was set by an independent
intensivist blinded for the EAdi and Pes aiming to
achieve optimal patient comfort, avoid unassisted wasted
inspiratory efforts, and minimize negative inspiratoryFigure 1 Schematic study protocol. After a baseline period of 30 minute
neurally adjusted ventilatory assist (NAVA) were applied in random order. A
predefined clinical criteria, and adequate NAVA (NAVAal) using a titration proc
a maximum 200% of NAVAal; NAVAlow, 50% of NAVAal; PSVhigh, 150% of PSdeflections in central venous and pulmonary artery pres-
sures (indicating inspiratory effort). PSVlow was 50% PSVal,
and PSVhigh was 150% PSVal. Positive end-expiratory pres-
sure (PEEP) and other prescribed ventilator settings were
kept constant throughout the protocol.
Adequate NAVA (NAVAal) was identified using a previ-
ously described titration procedure (Additional files 1 and 2
[6-9]). NAVAlow was 50% NAVAal, and NAVAhigh
was defined as the highest level sustaining a regular
breathing pattern similar to that at NAVAal or 200%
NAVAal, whichever occurred first.
The order of the ventilatory modes was randomized. The
six ventilator settings were applied for at least 20 minutes
each. All medications including sedation (Richmond
agitation and sedation scale of −1 to −2 [10]) remained
unchanged.
Measurements
Intravascular pressures, airway pressure, Pes, EAdi (as the
percentage of EAdi without assist at the beginning of
NAVA titration), and airflow were recorded continuously
(Neurovent Research Inc., Toronto, ON, Canada).
Pulmonary artery occlusion pressure, right ventricular
pressure, and blood gases were measured at the end of
each experimental period.
All signals were analyzed off-line breath by breath,
using a semi-automated detection of inspiration and
expiration based on airflow reversal [6-8]. Two approaches
were used to evaluate the hemodynamic responses. First,
intravascular pressure and Pes during all breaths in each
ventilator setting were averaged separately during
inspiration and expiration. This was done in order to
include the impact of variability in breathing pattern on
hemodynamics. Transmural vascular pressures were
obtained by subtraction of the time integral of Pess three levels of pressure support ventilation (PSV) and three levels of
dequate PSV (PSVal) was chosen by an independent intensivist using
edure [6-9]. NAVAhigh, highest level with constant breathing pattern or
Val; PSVlow, 50% of PSVal.
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intravascular pressures from inspiration to expiration
(cyclic pressure changes) were characterized by subtracting
the mean expiratory pressure from the mean inspiratory
pressure (Additional file 3). The mean inspiratory Pes
deflection was calculated for the duration of inspiratory air-
flow and was referenced to the Pes immediately preceding
the start of inspiratory airflow.
Second, representative single-breath cycles were manually
selected for each experimental period. The selected breaths
had mean inspiratory transpulmonary pressures equal to
the mean of all breaths for the specific study period
(the average breath). For each of these single breaths,
the central venous pressure (CVP) was measured at the
base of the c wave [11]. The right ventricular isovolumetric
pressure change was calculated as the difference between
the base of the c wave of CVP and the pulmonary
artery pressure (PAP) at valve opening [12], and the
right ventricular total pressure generation was calculated
as the pressure difference from the end-diastolic filling
of the right ventricle (estimated as the base of the
CVP c wave) to the systolic PAP. An example of this
analysis is given in Additional file 4.
Pulsed wave Doppler profiles from both ventricular
outflow tracts were recorded simultaneously with airway
pressure during transthoracic echocardiography and were
analyzed offline (Vivid 7, EchoPAC Dimension ‘06; GE
Medical Systems, Glattbrugg, Switzerland). End-inspiratory
and end-expiratory heart beats [13] from three ventilatoryTable 1 Characteristics of individual patients
Patient
number
PBW
(kg)
BMI
(kg/m2)
SAPS
II
ICU LOS
(days)
Perioperative
LVEF (%)
Prestudy PAO
(mmHg)
1 72 26 42 1.8 35 15
2 60 24 34 0.9 31 14
3 57 30 37 1.0 40 12
4 50 31 35 0.9 35 8
5 73 31 54 3.4 35 13
6 52 23 40 0.9 30 13
7 53 34 26 3.7 65 17
8 73 34 37 3.8 36 16
9 64 30 57 6.9 30 11
10 69 24 44 19.8 25 26
BMI, body mass index; CABG, coronary artery bypass graft; COPD, chronic obstructiv
fraction; PAOP, pulmonary artery occlusion pressure; PBW, predicted body weight; Scycles were analyzed for each condition. To characterize
the effects of lung inflation on the Doppler flow profiles,
the values at end inspiration were expressed as a percent-
age of the values at end expiration measured during the
same breathing cycle. A value >100% would thus reflect a
higher value during inspiration compared with expiration,
and vice versa.Statistical analysis
Repeated-measures analysis of variance (within-subject
factors: ventilation mode, support level) was used for
analysis. Significant mode*support level interactions were
analyzed post hoc within each mode between support levels
using Sidak’s correction (IBM SPSS 20.0.0; IBM Corp,
Armonk, NY, USA). Data are presented as mean ± standard
deviation. P <0.05 was considered significant.Results
Ten patients (age 66 ± 10 years; five females; Simplified
Acute Physiology Score II 41 ± 9) were studied (Table 1).
Figure 2 illustrates the respiratory pattern and cyclic
intravascular pressure changes for all experimental
conditions in a single patient.
Five patients with reduced left ventricular ejection
fraction and one patient with normal left ventricular
ejection fraction (Patient 7) received inotropic drug support
(dobutamine, mean dose 2.2 ± 1.9 μg/kg/minute), and four
patients with reduced left ventricular ejection fraction didP Prestudy cardiac
index (l/minute/m2)
Dobutamine during
study (μg/kg/minute)
Cardiopulmonary
diagnosis
1.4 3.1 CABG
2.6 3.8 CABG
3.2 0.0 CABG, COPD with
cor pulmonale
1.6 3.4 CABG, aortic valve
replacement
3.6 0.0 Cardiogenic shock
following myocardial
infarction
2.2 4.5 CABG, aortic valve
replacement, COPD
2.2 2.9 Aortic valve and
arch replacement
(type A dissection)
2.8 0.0 Aortic and mitral valve
replacement, COPD
3.0 3.9 CABG, aortic valve
replacement, mitral ring
3.1 0.0 Cardiogenic shock
following myocardial
infarction
e pulmonary disease; LOS, length of stay; LVEF, left ventricular ejection
APS, Simplified Acute Physiology Score.
Figure 2 Breathing pattern and cyclic transmural pressure changes in an individual patient (Patient 8). Negative deflections in esophageal
pressure (Pes) were preserved during inspiration with all neurally adjusted ventilatory assist (NAVA) levels, whereas Pes deflections were negative only with
the lowest pressure support ventilation (PSV) level and progressively positive with the adequate PSV (PSVal) and the highest PSV level (PSVhigh).
Transmural pressures were not much affected by ventilation with NAVA regardless of the assist level used, whereas the negative cyclic changes during
inspiration increased with increasing PSV levels. Vertical grey bars indicate the inspiration (defined by airflow) of the corresponding breath. CVP, central
venous pressure; EAdi, electrical activity of the diaphragm; NAVAal, adequate NAVA; NAVAhigh, highest level with constant breathing pattern or a
maximum 200% of NAVAal; NAVAlow, 50% of NAVAal; PAP, pulmonary artery pressure; Paw, airway pressure; PSVhigh, 150% of PSVal; PSVlow, 50% of PSVal.
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used for all valve surgery procedures.
NAVAal was identified at 3.1 ± 1.1 cmH2O/μV and
PSVal at 17 ± 2 cmH2O, with a PEEP of 7 ± 2 cmH2O
(Additional file 5). EAdi was lower with PSV than with
NAVA. The tidal volume and transpulmonary pressure
increased from NAVAlow to NAVAal and did not in-
crease further at NAVAhigh, whereas both parameters in-
creased with increasing PSV (Table 2 and Additional file
6). Table 2 presents data on the respiratory pattern and
the systemic hemodynamic function.
Transmural pressures
There was no difference between the modes in intravascular
or transmural CVP and PAP in expiration. The cyclicchanges (inspiratory minus expiratory values) in transmural
CVP were small with both NAVA and PSV, and decreased
with increasing level of support more prominently with
PSV (P = 0.03, level*mode interaction). The cyclic changes
in transmural PAP were negative for all NAVA levels
and PSVlow, and were positive for PSVal and PSVhigh
(P = 0.026, level*mode interaction; Table 3). The inspiratory
deflections in Pes became progressively positive with
increasing PSV, while they remained negative with all
NAVA levels (P < 0.001, level*mode interaction).
In the analysis of the representative single breath
(Figure 3, Table 4), the cyclic changes in transmural
CVP decreased with increasing support with both
NAVA and PSV (level effect P = 0.015). The transmural
CVP was higher in inspiration than in expiration at all
Table 2 Blood gases, respiratory pattern and systemic hemodynamic data
PSVlow PSVal PSVhigh NAVAlow NAVAal NAVAhigh P value
Level Mode Interaction
Blood gases
PaO2 (mmHg) 94 ± 21 94 ± 21 97 ± 21 94 ± 25 91 ± 25 94 ± 24 0.325 0.495 0.864
PaCO2 (mmHg) 38 ± 9 37 ± 8 36 ± 8 39 ± 10 39 ± 11 38 ± 9 <0.001 0.202 0.102
SaO2 (%) 97 ± 2 97 ± 1 98 ± 2 97 ± 2 97 ± 2 97 ± 2 0.174 0.309 0.782
pH 7.41±0.1 7.43±0.1 7.45 ± 0.1 7.42 ± 0.1 7.43±0.1 7.43 ± 0.1 <0.001 0.464 0.164
Base excess 0.2 ± 3.6 0.3 ± 3.6 0.1 ± 3.6 0.4 ± 3.5 0.5 ± 3.5 0.5 ± 3.5 0.194 0.244 0.592
Respiratory pattern
Respiratory rate (breaths/minute) 21 ± 5 18 ± 4 13 ± 3 20 ± 5 21 ± 5 20 ± 6 <0.001 0.041 <0.001
Tidal volume (ml/kg PBW) 6.3 ± 1.1 8.2 ±1.8 11.4 ± 3.0 6.7 ± 1.2 7.0 ± 1.2 7.6 ± 1.2 <0.001 0.018 0.001
Minute ventilation (l/minute) 7.7 ± 2.0 8.6 ±2.5 8.7 ± 2.1 8.1 ± 2.7 8.6 ± 2.5 8.7 ± 3.0 <0.001 0.619 0.361
Electrical activity of the diaphragm (% EAdi max) 61 ± 16 32 ± 11 17 ± 9 90 ± 33 71 ± 19 29 ± 25 <0.001 0.002 0.3
Mean inspiratory transpulmonary pressure (cmH2O) 3 ± 4 5 ± 4 10 ± 4 3 ± 3 3 ± 4 7 ± 5 <0.001 0.158 <0.001
Mean esophageal pressure deflection (cmH2O) −0.7±1.5 2.1 ±1.9 4 ± 2.3 −1.5 ± 2.4 −1.5±1.7 0 ± 1 0.001 <0.001 <0.001
Systemic hemodynamic data
Pulmonary artery occlusion pressure (mmHg) 16 ± 7 14 ± 4 15 ± 7 15 ± 7 15 ± 5 16 ± 6 0.516 0.424 0.241
Mean systemic arterial pressure (mmHg) 65 ± 8 61 ± 9 65 ± 9 65 ± 9 63 ± 9 63 ± 9 0.065 0.922 0.256
Heart rate (beats/minute) 90 ± 9 90 ± 9 89 ± 9 89 ± 10 90 ± 10 88 ± 10 0.3 0.831 0.567
Cardiac output (l/minute) 4.7 ± 0.9 4.8 ± 0.7 4.8 ± 0.7 5.2 ± 1.2 5.1 ± 1.1 5.1 ± 1.2 0.964 0.082 0.284
Mixed venous oxygen saturation (%) 66 ± 7 64 ± 5 66 ± 9 63 ± 5 65 ± 7 62 ± 5 0.469 0.059 0.211
Data presented as mean ± standard deviation. P values from repeated-measures analysis of variance (within-subject factors: ventilation mode, support level). NAVA,
neurally adjusted ventilator assist; NAVAal, adequate NAVA level identified by a titration procedure; NAVAhigh, 200% of the adequate NAVA level; NAVAlow, 50%
of the adequate NAVA level; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen; PBW, predicted body weight; PSV, pressure support
ventilation; PSVal, adequate level of pressure support ventilation identified on clinical grounds; PSVhigh, 150% of adequate PSV level; PSVlow, 50% of adequate
PSV level; SaO2, oxygen saturation in arterial blood.
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CVP during expiration than during inspiration (mode
effect P = 0.015).
Right ventricular ejection
The transmural inspiratory isovolumetric pressure
change increased with increasing pressure support,
whereas it remained unchanged with increasing
NAVA levels (P = 0.005, level*mode interaction;
Table 4). Accordingly, the cyclic alterations (inspira-
tory minus expiratory values) in the isovolumetric
pressure change increased with increasing pressure
support and remained unchanged with NAVA (P =
0.003, level*mode interaction; Figure 3). A similar
pattern was observed for the cyclic changes in the
total transmural pressure generation of the right
ventricle from central venous end diastolic pressure
to systolic pulmonary artery pressure (P = 0.033,
level*mode interaction).
Both the ventilation mode and support level modi-
fied the right ventricular Doppler flow patterns
(Table 5, Figure 4). During inspiration the flow periodand the velocity time integral in the right ventricular
outflow tract (RVOT VTI, a surrogate of stroke vol-
ume) both progressively decreased with increasing
PSV level, whereas they remained unchanged with in-
creasing NAVA levels (P = 0.028 for flow period and
P = 0.025 for RVOT VTI, level*mode interaction).
RVOT VTI was equal or higher during inspiration
compared with expiration for all NAVA levels. With
PSV, RVOT VTI was equal during inspiration and
expiration only with PSVlow but it was clearly lower
during inspiration compared with expiration with
PSVal and PSVhigh (P < 0.001, level*mode inter-
action). The highest RVOT VTI during inspiration
compared with expiration was observed with
NAVAal (109 ± 5%). The right ventricular stroke vol-
ume, as reflected by the RVOT VTI, during inspir-
ation was thus preserved with all NAVA levels
whereas it progressively decreased with increasing
PSV level.
The left ventricular echocardiography results are
summarized in Additional file 7. No relevant differences
were observed between the modes.
Table 3 Mean central venous and mean pulmonary artery pressures for the entire experimental period
PSVlow PSVal PSVhigh NAVAlow NAVAal NAVAhigh P value
Level Mode Interaction
Expiratory values
Central venous pressure (mmHg) 10 ± 3 10 ± 3 10 ± 3 11 ± 3 10 ± 3 11 ± 3 0.064 0.091 0.919
Mean pulmonary artery pressure (mmHg) 30 ± 8 27 ± 6 27 ± 6 30 ± 5 29 ± 5 28 ± 5 0.002 0.065 0.208
Transmural central venous pressure (mmHg) 3 ± 4 1 ± 5 2 ± 4 5 ± 4 2 ± 3 3 ± 3 0.06 0.267 0.566
Transmural mean pulmonary artery pressure
(mmHg)
22 ± 9 18 ± 8 19 ± 7 24 ± 6 21 ± 5 21 ± 6 <0.001 0.091 0.683
Cyclic pressure changes
Central venous pressure (mmHg) −0.5 ± 0.4 0.4 ± 0.4 1.0 ± 0.4 −1 ± 0.5 −0.8 ± 0.6 −0.5 ± 0.7 <0.001 <0.001 <0.001
Mean pulmonary artery pressure (mmHg) −2.2 ± 1.1 0.5 ± 1.4 2.5 ± 1.3 −3.2 ± 0.9 −2.7 ± 1.2 −1.9 ± 1 <0.001 <0.001 <0.001
Transmural central venous pressure (mmHg) 1.3 ± 1.6 0± 0.9 −0.9 ± 1.1 1.4 ± 2.4 1.6 ± 1.6 0.1 ± 1.8 0.009 0.08 0.03
Transmural mean pulmonary artery
pressure (mmHg)
−0.3 ± 1.8 0.1 ± 0.8 0.5 ± 0.8 −0.8 ± 2.1 −0.4 ± 1.3 −1.2 ± 1.9 0.479 0.078 0.026
Data presented as mean ± standard deviation. Central venous and pulmonary artery pressures (zeroed to atmosphere) and their respective transmural values for
the different experimental periods. The transmural values were calculated by subtraction of the esophageal pressure. Cyclic pressure changes are the differences
between mean inspiratory and mean expiratory pressures. Data reflect mean values from the analysis of the entire experimental periods. P values from
repeated-measures analysis of variance (within-subject factors: ventilation mode, support level). NAVA, neurally adjusted ventilator assist; NAVAal, adequate NAVA level
identified by a titration procedure; NAVAhigh, 200% of the adequate NAVA level; NAVAlow, 50% of the adequate NAVA level; PSV, pressure support ventilation; PSVal,
adequate level of pressure support ventilation identified on clinical grounds; PSVhigh, 150% of adequate PSV level; PSVlow, 50% of adequate PSV level.
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The main finding of this study was that ventilation with
NAVA in patients with impaired cardiac function but stable
hemodynamics avoided an inspiratory increase in right
ventricular outflow impedance by preserving the cyclic,
negative deflections in intrathoracic pressure via feedback
control of transpulmonary pressure and tidal volume. The
hemodynamic pattern during NAVA closely resembled thatInspiratory Pes Deflection [cmH2O]
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Figure 3 Loading conditions of the right ventricle in the average brea
pressure was measured at the base of the c wave. (A) Inspiratory minus ex
and mode. (B) Inspiratory minus expiratory transmural isvolumetric pressur
mode interaction. Values presented as mean ± standard deviation. NAVA, n
identified by a titration procedure; NAVAhigh, 200% of the adequate NAVA
pressure; PSV, pressure support ventilation; PSVal, adequate level of pressur
adequate PSV level; PSVlow, 50% of adequate PSV level.of unassisted spontaneous breathing, regardless of the
NAVA level used. In contrast, increased inspiratory assist
with PSV progressively increased right ventricular outflow
impedance, transpulmonary pressure, and tidal volume.
The pattern of decreasing right and increasing left
ventricular stroke volume during inspiration is the
characteristic pattern of heart–lung interactions during
positive pressure ventilation [13-16]. The mechanisms ofInspiratory Pes Deflection [cmH2O]
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th. Analysis of the single representative breath cycle. Central venous
piratory transmural central venous pressure (ΔCVP), P = 0.015 for level
e (Δisovolumetric pressure), P = 0.003 for support level–ventilation
eurally adjusted ventilator assist; NAVAal, adequate NAVA level
level; NAVAlow, 50% of the adequate NAVA level; Pes, esophageal
e support ventilation identified on clinical grounds; PSVhigh, 150% of
Table 4 Loading conditions of the right ventricle in the average breath
PSVlow PSVal PSVhigh NAVAlow NAVAal NAVAhigh P value
Level Mode Interaction
Transmural central venous pressures
at c wave
End expiratory (mmHg) 2.6 ± 4 1.3 ± 5.1 2.3 ± 4.1 4.2 ± 4.5 2.4 ± 2.5 3.1 ± 3.4 0.331 0.018 0.817
End inspiratory (mmHg) 4.8 ± 4.5 1.5 ± 4.3 1.5 ± 3.9 6.6 ± 3.0 3.6 ± 3.3 4.2 ± 2.2 0.001 0.1 0.697
Cyclic change (mmHg) 2.2 ± 3 0.3 ± 1.7 −0.8 ± 2.1 2.4 ± 4 1.2 ± 1.2 1.1 ± 2.4 0.015 0.015 0.303
Isovolumetric pressure generation
Inspiratory transmural isovolumetric pressure
(mmHg)
11 ± 4.6 12.3 ± 4.4 14 ± 4.6 11.5 ± 4.7 11.1 ± 4.6 10.8 ± 4.2 0.057 0.095 0.005
Expiratory transmural isovolumetric pressure
(mmHg)
12.7 ± 4.7 11.5 ± 4.5 12 ± 5.2 12.8 ± 4.1 12.8 ± 3.7 12.1 ± 4.7 0.266 0.257 0.318
Cyclic change in transmural isovolumetric
pressure (mmHg)
−1.8 ± 1.4 0.8 ± 2.2 2 ± 2 −1.3 ± 1 −1.8 ± 2.1 −1.3 ± 1.1 0.003 0.009 0.003
Total pressure generation
Inspiratory transmural pressure generation
(mmHg)
29.7 ± 10.7 27.2 ± 7.8 29.6 ± 9.4 29.8 ± 9.6 26.9 ± 8.5 26.9 ± 7 0.06 0.38 0.561
Expiratory transmural pressure generation
(mmHg)
30.4 ± 10.8 23.5 ± 8.3 26.5 ± 9.4 28.6 ± 10.4 27.9 ± 8 27 ± 6.9 0.231 0.053 0.241
Cyclic change in transmural pressure
generation (mmHg)
−0.7 ± 2.3 3.8 ± 8 3.1 ± 1.5 1.2 ± 3.7 −1 ± 4.5 0 ± 2 0.543 0.076 0.033
Data presented as mean ± standard deviation. Data derived from the analysis of the single average breath with measurement of the central venous pressure (CVP)
at the base of the c wave. Isovolumetric pressure generation was calculated as the difference between pulmonary artery pressure at valve opening and CVP at the
c wave, and the total pressure generation as systolic pulmonary artery pressure minus CVP at the c wave. P values from repeated-measures analysis of variance
(within-subject factors: ventilation mode, support level). NAVA, neurally adjusted ventilator assist; NAVAal, adequate NAVA level identified by a titration procedure;
NAVAhigh, 200% of the adequate NAVA level; NAVAlow, 50% of the adequate NAVA level; PSV, pressure support ventilation; PSVal, adequate level of pressure
support ventilation identified on clinical grounds; PSVhigh, 150% of adequate PSV level; PSVlow, 50% of adequate PSV level.
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changes in venous return and consequent ventricular
filling [17-19], and changes in outflow impedance [2,12].
Although these mechanisms have been known for
decades, their implications and relevance during NAVA
have not been addressed. Specifically, the actual pleural
and transmural pressure profiles resulting from clinical
application of NAVA will define the cardiac effects of
NAVA. These have not been described before. In this
respect, our study provides mechanistic insight into the
heart–lung interactions of NAVA in a clinically relevant
and realistic setting. We used RVOT VTI as a surrogate
for right ventricular stroke volume assuming that the
pulmonary valve annulus area does not vary with respiration
[2]. The progressive reduction in inspiratory RVOT VTI,
flow period and maximum flow velocity, and inspiratory
increases in right ventricular isovolumetric contraction
pressure with increasing PSV indicate increased impedance
to right ventricular outflow [12]. In contrast, during all
NAVA levels, right ventricular outflow impedance was
lower during inspiration than during expiration, as
indicated by increased inspiratory RVOT VTI, flow period
and maximum flow velocity and reduced right ventricular
isovolumetric contraction pressure. Reduced right
ventricular afterload during inspiration with NAVAand increased inspiratory afterload with PSV is further
supported by negative correlation between inspiratory
changes in RVOT VTI and Pes (reflecting pleural
pressure; Figure 4) and the decreased RVOT VTI
with increased pressures in the pressure/flow diagrams
(Additional file 8) [20].
Reduced right ventricular preload due to positive
pressure ventilation-associated reduction in venous return
[17,19,21] was also likely to contribute to changes in
RVOT VTI. Since we did not measure pericardial
pressure, we have no direct estimates of right ventricular
end-diastolic wall tension. The transmural pressure at the
base of the c wave of the CVP tracing, a surrogate of right
ventricular end-diastolic wall tension, decreased slightly but
significantly with increasing support both in inspiration and
expiration without difference between modes. This result
should be interpreted with caution, since pleural pressure
may not adequately reflect pericardial pressure [22].
Nevertheless, even if changes in preload were involved,
the increased right ventricular isovolumetric contraction
pressure in the presence of reduced RVOT VTI indicates
increased impedance to right ventricular ejection [12] in
inspiration with PSV, and the opposite changes indicate
reduced impedance to ejection during inspiration with
NAVA. The increase in the right ventricle afterload
Table 5 Right ventricular echocardiographic data
Doppler flow profile in the right ventricular
outflow tract (n = 8)
PSVlow PSVal PSVhigh NAVAlow NAVAal NAVAhigh P value
Level Mode Interaction
End expiration
Acceleration time (milliseconds) 82 ± 14 83 ± 13 80 ± 11 82 ± 16 77 ± 14 89 ± 18 0.484 0.68 0.141
Flow period (milliseconds) 242 ± 25 256 ± 36 256 ± 37 240 ± 23 242 ± 27 243 ± 28 0.072 0.127 0.285
Maximum flow velocity (m/second) 0.8 ± 0.2 0.9 ± 0.3 0.8 ± 0.3 0.7 ± 0.3 0.8 ± 0.2 0.9 ± 0.3 0.047 0.012 0.465
Velocity time integral (cm) 13 ± 2 14 ± 3 14 ± 3 13 ± 2 13 ± 3 14 ± 3 0.009 0.063 0.178
End inspiration
Acceleration time (milliseconds) 86 ± 15 81 ± 15 84 ± 17 81 ± 12 88 ± 20 91 ± 17 0.62 0.259 0.296
Flow period (milliseconds) 250 ± 27 242 ± 25 231 ± 33 250 ± 21 261 ± 29 251 ± 30 0.02 0.067 0.028
Maximum flow velocity (m/second) 0.8 ± 0.2 0.8 ± 0.3 0.7 ± 0.2 0.7 ± 0.3 0.9 ± 0.3 0.8 ± 0.3 0.168 0.154 0.166
Velocity time integral (cm) 13 ± 3 13 ± 3 12 ± 3 13 ± 2 14 ± 3 14 ± 3 0.154 0.046 0.025
Inspiratory values as percentage of expiratory
values
cAcceleration time (%) 104 ± 8 98 ± 8 105 ± 10 101 ± 13 115 ± 9 104 ± 11 0.617 0.217 0.012
Flow period (%) 103 ± 2 94 ± 3 91 ± 2 104 ± 2 107 ± 3 103 ± 2 <0.001 <0.001 <0.001
Maximum flow velocity (%) 99 ± 2 92 ± 7 86 ± 8 100 ± 3 106 ± 5 97 ± 4 <0.001 0.003 <0.001
Velocity time integral (%) 101 ± 3 89 ± 6 83 ± 9 103 ± 4 109 ± 5 100 ± 4 <0.001 <0.001 <0.001
Data presented as mean ± standard deviation. Doppler flow profiles in the right ventricular outflow tract could be obtained from eight patients. Absolute values at
end expiration did not differ between NAVA and PSV. To describe cyclic changes, the inspiratory values are given as a percentage of the corresponding expiratory
value. P values from repeated-measures analysis of variance (within-subject factors: ventilation mode, support level). NAVA, neurally adjusted ventilator assist;
NAVAal, adequate NAVA level identified by a titration procedure; NAVAhigh, 200% of the adequate NAVA level; NAVAlow, 50% of the adequate NAVA level; PSV,
pressure support ventilation; PSVal, adequate level of pressure support ventilation identified on clinical grounds; PSVhigh, 150% of adequate PSV level; PSVlow,
50% of adequate PSV level.
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volumes [23-25]. Our results clearly indicate the pres-
ence of this mechanism also at low tidal volumes,
although it did not compromise cardiac performance
in our patients with stable hemodynamics to a clinic-
ally relevant extent.
Mean inspiratory Pes deflection increased progressively
with increasing PSV, whereas the initially slightly negative
Pes deflection approached zero with increasing NAVA
levels, but did not increase further. This may be related to
a progressive downregulation of EAdi with increasing
NAVA level, and might limit the effect of NAVA on right
ventricular function. Such feedback mechanisms have
been previously observed in healthy volunteers and
mechanically ventilated patients with acute respiratory
failure [6-8,26].
Study limitations
Several limitations must be addressed. The study was
carried out to demonstrate the underlying physiology;
due to safety concerns, patients with impaired cardiac
function but stable hemodynamic and metabolic conditions
were studied for short periods only. Hence, the relevance
and consequences of treatment, if any, of these potentially
beneficial effects of NAVA should be evaluated furtherin hemodynamically unstable patients with compro-
mised right ventricular function and in patients with
deranged metabolic conditions or with hypercapnia or
hypoxemia – clinical conditions where substantial
unloading of respiratory muscles with minimum comprom-
ise of right ventricular function may be considered.
Most of the patients were studied during the first day
after cardiac surgery. Despite being clinically stable, some
of these patients could have had relevant intravascular
volume changes. In fact, hypovolemia is known to ag-
gravate cyclic intravascular pressure swings [27-29].
Despite potential differences in preload status, the observed
hemodynamic response seem consistent within and among
individual patients.
There is no standard approach to titrate NAVA. We
previously used the same NAVAal titration for several
days in ICU patients with critical illness associated poly-
neuromyopathy (CIPM) without progression to respira-
tory distress, suggesting that NAVAal provides sufficient
respiratory support [8].The average PSV adjusted by the
clinicians in charge was based on clinical evaluation of
patient comfort, and as a substitute for inspiratory effort,
to minimize the cyclic changes in intrathoracic intravas-
cular pressures. The resulting relatively high PSV can be
criticized for augmenting the effects of PSV on right
Mean Inspiratory Pes Deflection [cmH2O]
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Figure 4 Right ventricular outflow during the respiratory cycle.
The velocity time integral in the inspiratory right ventricular outflow
tract (RVOT VTI) as a percentage of its expiratory value. There is a
significant increase in RVOT VTI during inspiration for all NAVA
levels compared to PSV (P < 0.001, level*mode interaction). Data
presented as mean ± standard deviation. NAVA, neurally adjusted
ventilator assist; NAVAal, adequate NAVA level identified by a
titration procedure; NAVAhigh, 200% of the adequate NAVA level;
NAVAlow, 50% of the adequate NAVA level; Pes, esophageal
pressure; PSV, pressure support ventilation; PSVal, adequate level of
pressure support ventilation identified on clinical grounds; PSVhigh,
150% of adequate PSV level; PSVlow, 50% of adequate PSV level.
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likely to have reduced chest wall compliance due to
obesity and recent cardiac surgery. The average level of
PSV also coincided with the reported average level associ-
ated with best patient comfort in difficult to wean patients
[30]. PEEP may influence respiratory drive and assist re-
quirements [7], but PEEP was kept constant and should
not have influenced the changes within patients. Fi-
nally, since PSV and NAVA result in different flow
patterns and as flow reversal was used to identify the
transition between inspiration and expiration, the in-
vestigators could not be blinded to the mode used when
analyzing the data.
Conclusions
In patients with impaired cardiac function, right ven-
tricular performance is less impaired during NAVA
titrated to the breathing pattern compared with PSV
selected based on clinical criteria. Proposed mechanisms
are preservation of cyclic intrathoracic pressure changes
characteristic of spontaneous breathing and limitation of
right-ventricular outflow impedance during inspiration,
regardless of the NAVA level. Thus, NAVA not only
prevents lung overdistension and potentially dia-
phragm disuse, but also the characteristic side effects
of positive pressure ventilation on right ventricular
function.Key messages
 During NAVA, a ventilatory mode that delivers
assist in proportion to the neural inspiratory effort,
the right-ventricular hemodynamic pattern
resembles that of unassisted spontaneous breathing,
regardless of the NAVA level used.
 The proposed mechanism includes a lack of increase
in right ventricular outflow impedance and a lack of
decrease in venous return during lung inflation.
 During NAVA, lung inflation and tidal volume are
restricted by neural feedback, while near-zero negative
deflections in intrathoracic pressure are preserved.
Additional files
Additional file 1: Is an online supplement containing additional
details for the Materials and Methods section.
Additional file 2: Shows the NAVA level titration procedure as
described previously [6-9]. The NAVA level was reduced to a minimum
of 0 cmH2O/μl resulting in delivery of 2 cmH2O (default assist level) when
the inspiratory effort exceeded the pneumatic trigger threshold. When
sufficient electrical activity of the diaphragm (EAdi, green tracing; middle
plot) was detectable, the NAVA level (white tracing; uppermost plot) was
manually increased by 0.1 cmH2O/μV every 20 seconds. By observing the
airway pressure (Paw, yellow tracing; uppermost plot) and tidal volume
(Vt, blue tracing; lowermost plot) on the trend screen of the ventilator
monitor, NAVAal was determined as the NAVA level early after the
transition from an initial steep increase in Paw and Vt (first response) to a
less steep increase or even plateau in Paw and Vt (second response).
NAVAlow was arbitrarily defined as 50% of NAVAal. NAVAhigh was
defined as the highest level resulting in a breathing pattern similar to
that observed at NAVAal (that is, before the breathing pattern became
unstable and airway pressure started to increase further) [6] or at 200% of
NAVAal, whatever occurred first.
Additional file 3: Is a schematic representation of changes in
intravascular pressures over the respiratory cycle. The sample is
recorded during ventilation with pressure support (PSV). In order to
assess the cyclic change in pressures, the mean expiratory values
(represented by the green bar) for central venous, pulmonary artery and
systemic arterial pressures were subtracted from their respective mean
inspiratory values (represented by the red bar). Thus, a positive result
(that is, positive cyclic pressure change) indicates that the pressure was
higher during inspiration compared to expiration.
Additional file 4: shows the single-breath analysis. A single breath
(Patient 1, PSVal) was manually selected, based on the mean inspiratory
transpulmonary pressure retrieved from the semi-automated analysis.
The image thus represents the average breath of this patient in this
experimental period. CVP at the base of the c wave (red circles), the
opening pressure of the pulmonary valve (blue circles) and the systolic
pulmonary artery pressure (green circle) were measured together with
their corresponding esophageal pressure (grey circle). The measurements
were taken in the cardiac beats closest to end inspiration and end
expiration.
Additional file 5: Is a table presenting the individual ventilator
settings for all patients studied. FiO2, fraction of inspired oxygen; PEEP,
positive end-expiratory pressure; PSV, pressure support ventilation; EAdi,
electrical activity of the diaphragm; NAVA, neurally adjusted ventilatory
assist; Insp rise, inspiratory rise time.
Additional file 6: Shows the breathing pattern and transpulmonary
pressures. Left: Respiratory cycle and tidal volume for each experimental
condition. PBW, predicted body weight [31]. While remaining constant
under NAVA, the tidal volume increased (P < 0.001 for level*mode
interaction) and the duty cycle (the inspiratory proportion total cycle
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http://ccforum.com/content/18/5/499time) and respiratory rate decreased (P < 0.005 and P < 0.001 respectively,
level*mode interaction) with increasing the PSV level. NAVA, neurally
adjusted ventilatory assist; PSV, pressure support ventilation; respective
support levels, low, al (adequate level), and high. Values presented as
mean ± standard deviation. Right: Transpulmonary pressure (Ptp) isobars
(dotted ascending lines). Transpulmonary pressure increased from
NAVAlow to NAVAal but remained stable when further increasing the
assist to NAVAhigh. With PSV the transpulmonary pressure steadily
increased from PSVlow to PSVhigh. Mean inspiratory airway pressure
(including PEEP) and Ptp were lower during NAVA compared with the
corresponding PSV levels (P < 0.05 for all, level*mode interaction). Mean
inspiratory esophageal pressure deflection was negative for all NAVA
levels, whereas it was negative only for PSVlow and positive for PSVal
and PSVhigh (P < 0.001 for all comparisons).
Additional file 7: Is a table presenting Doppler flow profiles in the
left ventricular outflow tract could be obtained from seven
patients. Absolute values at end expiration did not differ between NAVA
and PSV. To describe cyclic changes, the inspiratory values are given as a
percentage of the corresponding expiratory value. Values are mean ± standard
deviation. *P values from repeated-measures analysis of variance (ANOVA;
within-subject factors: ventilation mode, support level).
Additional file 8: Shows the pressure/flow relationships. To support
the concept of increasing inspiratory impedance to flow during PSV, we
have constructed figures plotting the cyclic changes (inspiratory minus
expiratory values) for absolute mean pulmonary artery pressure
(referenced to atmosphere (A)) and for transmural mean pulmonary
artery pressure (referenced to esophageal pressure (B)) against cyclic
changes (inspiratory minus expiratory value) in RVOT VTI, assuming that
the RVOT VTI is an adequate surrogate of right ventricular (RV) stroke
volume [2]. The common starting point in the center represents the
expiration, the movement along the vector the change in inspiration. The
simultaneous increase in stroke volume and reduction of transmural
pulmonary artery pressure during inspiration and increase in RV stroke
volume (lower right quadrant) is consistent with reduced RV afterload,
whereas increasing PSV leads to reduction of stroke volume and unchanged
or increased pulmonary artery pressure during inspiration, which is consistent
with increased RV afterload [20]. This analysis assumes similar changes in left
atrial pressure from inspiration to expiration [32,33]. Values are means.
Abbreviations
CVP: central venous pressure; EAdi: electrical activity of the diaphragm;
NAVA: neurally adjusted ventilator assist; NAVAal: adequate neurally adjusted
ventilator assist level identified by a titration procedure; NAVAhigh: 200% of
the adequate neurally adjusted ventilator assist level; NAVAlow: 50% of the
adequate neurally adjusted ventilator assist level; PAP: pulmonary artery
pressure; PEEP: positive end-expiratory pressure; Pes: esophageal pressure;
PSV: pressure support ventilation; PSVal: adequate level of pressure support
ventilation identified on clinical grounds; PSVhigh: 150% of adequate
pressure support level; PSVlow: 50% of adequate pressure support level;
RVOT VTI: velocity time integral in right ventricular outflow tract.
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